40 results
8-K
EX-10.2
1rgix6
29 Jun 23
Departure of Directors or Certain Officers
4:25pm
8-K
EX-10.1
5jnjcb72viy9gkwkfo
29 Jun 23
Departure of Directors or Certain Officers
4:25pm
8-K
EX-10.1
id5ar39 cv
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
424B3
9bmzk33hk
20 Apr 23
Prospectus supplement
4:32pm
S-4/A
0cfh20a
18 Apr 23
Registration of securities issued in business combination transactions (amended)
4:01pm
S-4
dzgzk66imev3akya wz
5 Apr 23
Registration of securities issued in business combination transactions
4:40pm